| 2023/10/05 - 18:00 |
|
Contract Pharma - Abionyx Pharma Manufactures First Batch of CER-001 with Recombinant Human ApoA-I
|
pdf
|
| 2023/19/01 - 09:57 |
|
Scrip - Abionyx Looks To Next Steps As Renal Sepsis Candidate Succeeds At Phase IIa
|
pdf
|
| 2023/17/01 - 19:00 |
|
FierceBiotech - Abionyx hails success of bid to resurrect failed cholesterol drug—without dishing data to back up claims
|
www |
| 2023/17/01 - 10:00 |
|
European Biotechnology - Abionyx Pharma announces success in fighting sepsis-triggered AKI
|
pdf
|
| 2023/17/01 - 10:00 |
|
Clinical Trials Arena - Abionyx Pharma’s Phase IIa trial of CER-001 for AKI meets primary objective
|
pdf
|
| 2023/17/01 - 10:00 |
|
The Pharma Letter - Abionyx bullish on acute kidney injury drug’s prospects
|
pdf
|
| 2023/17/01 - 10:00 |
|
European Clinical Review - Potential treatment identified for septic patients
|
pdf
|
